| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Armata Pharmaceuticals, Inc. | Chief Business Officer | Common Stock | 9,461 | $90,257 | $9.54 | 14 Mar 2026 | Direct |
| Armata Pharmaceuticals, Inc. | Chief Business Officer | Stock Options (Right to Buy) | 183,142 | 09 Mar 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARMP | Armata Pharmaceuticals, Inc. | 14 Mar 2026 | 1 | $0 | 4 | Chief Business Officer | 17 Mar 2026, 19:48 |
| ARMP | Armata Pharmaceuticals, Inc. | 09 Mar 2026 | 1 | $0 | 4 | Chief Business Officer | 11 Mar 2026, 21:18 |
| ARMP | Armata Pharmaceuticals, Inc. | 14 Mar 2025 | 1 | -$2,003 | 4 | Chief Business Officer | 25 Apr 2025, 16:06 |
| ARMP | Armata Pharmaceuticals, Inc. | 05 Feb 2025 | 1 | $0 | 4 | Chief Business Officer | 07 Feb 2025, 16:19 |
| ARMP | Armata Pharmaceuticals, Inc. | 19 Jun 2024 | 0 | $0 | 3/A | Chief Business Officer | 25 Apr 2025, 16:05 |